News Cover
Science

CSIR submits 53 genome sequences of coronavirus to international physique; to share 450 extra by May 15

Amidst issues that coronavirus have undergone mutation and the brand new pressure possibly extra contagious, India’s premier R&D organisation, CSIR, has submitted as many as 53 genome sequences of the virus to a world genome database, a transfer that will assist in higher understanding of the virus and creating a vaccine.

The Council for Scientific and Industrial Research (CSIR) can be planning to submit extra 450 genome sequence information of coronavirus by May 15, its Director General Shekhar Mande informed PTI.

CSIR’s Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institute of Microbial Technology, Chandigarh are presently sequencing the genomes of the novel coronavirus, he mentioned. Other CSIR institutes are additionally anticipated to affix the method.

“We have so far submitted 53 genome sequences to the GISAID (Global Initiative on Sharing All Influenza Data). By May 15, we intend to submit additional 450 genome sequences,” Mande mentioned, including all 53 have been sequenced by the scientists on the IGIB.

Genome sequencing is determining the order of DNA nucleotides. It helps in understanding how genes work collectively to direct the expansion, improvement and upkeep of an organism.

IGIB Director Anurag Agarwal mentioned in case of coronavirus, sequencing will assist perceive the origins of the virus.

For occasion, if a virus emerges from a specific cluster, sequencing will make it simpler to determine its origin later when it’s present in another a part of the nation or world. Plus, it is going to be useful in making the vaccines and medicines for it, he added.

Earlier this week, a examine by a US-based science laboratory has indicated that there’s a new, highly-potent pressure of coronavirus that has unfold globally and is extra contagious than the virus in early days of the COVID-19 pandemic.

In the Indian context, Mande mentioned the sequences submitted to the GISAID by the CSIR offers with the coronavirus detected in Indians.

Launched in 2008, the GISAID, a public-private partnership between the German authorities and the non-profit group, promotes the fast sharing of information from all influenza viruses and the coronavirus inflicting COVID-19.

This contains genetic sequence and associated medical and epidemiological information related to human viruses, and geographical in addition to species-specific information linked to avian and different animal viruses.

This allows researchers to know how viruses evolve and unfold throughout epidemics and pandemics.

According to GISAD, greater than 16,000 genome sequences of the coronavirus have been shared with it by totally different institutes on the planet which can allow fast progress within the understanding of the brand new COVID-19 illness and within the analysis and improvement of medical countermeasures.

“Genomic resources obtained from this sequencing will also allow identification of new targets for diagnosis and drugs for COVID-19,” Sanjeev Khosla, Director, IMTech had mentioned when the method had begun.

Besides, CSIR, the National Institute of Virology, Pune beneath the Indian Council of Medical Research and Gujarat Biotechnology Research Centre, a state sponsored institute, have additionally submitted genome sequences of coronavirus to the GISAID database. But the variety of sequences submitted by CSIR is excessive.

The CSIR, a physique beneath the Ministry of Science and Technology, has 38 laboratories coping with a variety of topics.

Globally, greater than 38 lakh individuals have been contaminated by coronavirus, and over 2.6 lakh individuals have died because of COVID-19, in accordance with the World Health Organisation database.

Related posts

Leave a Comment